论文部分内容阅读
目的评价血必净注射液治疗重症肺炎致全身炎症反应综合征的有效性。方法将84例重症肺炎患者随机分为治疗组和对照组,对照组采取基础治疗,治疗组除基础治疗外,用血必净注射液50mL加生理盐水100mL静脉滴注,每日2次。比较两组临床疗效、治疗前后炎症指标C反应蛋白(CRP)、体温(T)、白细胞计数(WBC)指标变化。结果治疗组有效率显著提高,WBC、T、CRP指标改善也优于对照组。结论血必净注射液具有良好的抗炎作用,在重症肺炎的治疗中有积极的作用。
Objective To evaluate the effectiveness of Xuebijing Injection in treating systemic inflammatory response syndrome caused by severe pneumonia. Methods Eighty-four patients with severe pneumonia were randomly divided into treatment group and control group. The control group received basic treatment. In addition to basic treatment, Xuebijing injection 50mL normal saline 100mL intravenous drip twice daily. The clinical curative effect was compared between the two groups before and after treatment. The indexes of CRP, body temperature (T) and white blood cell count (WBC) were observed before and after treatment. Results The treatment group significantly improved the efficiency, WBC, T, CRP indicators improved better than the control group. Conclusion Xuebijing injection has a good anti-inflammatory effect, in the treatment of severe pneumonia have a positive effect.